Crossmark

Effectiveness of a Japanese multi-professional cooperative osteoporosis liaison service at a private hospital for decreasing secondary fractures in osteoporosis patients with fragility fractures

Crossref DOI link: https://doi.org/10.1007/s11657-021-00924-7

Published Online: 2021-04-22

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yoshino, Yasumasa

Tanaka, Shinya

Ohama, Hikaru

Kobayashi, Saori

Tobita, Hideki

Kuwagaki, Kanae

Fujioka, Rie

Totsuka, Hiroaki

Ichiba, Yuka

Ishimine, Sachiko

Sakamoto, Kazumi

Kubo, Toshiro
License Information

Text and Data Mining valid from 2021-04-22

Version of Record valid from 2021-04-22
More Information

Article History

Received: 1 November 2020

Accepted: 23 March 2021

First Online: 22 April 2021

Declarations

:

: Yasumasa Yoshino has received speaker honorariums from Asahi Kasei Pharma Corporation, Taisyo Pharmaceutical Holdings, Pfizer Japan Inc., and Eli Lilly Japan K.K. Shinya Tanaka has received speaker honorariums from Teijin Pharma Ltd., Asahi Kasei Pharma Corporation, Astellas Pharma Inc., Amgen Inc., Taisyo Pharmaceutical Holdings, and Eisai Co., Ltd. All other authors declare no competing interests.

Document is current

Any future updates will be listed below